Concepedia

Oliver Keil

OK

Statistics

Publications

22

Citations

1.8K

H-Index

17

Active since

1995

Affiliations

University of Wuppertal(Current)

Medizinische Hochschule Hannover

Max Delbrück Center

Silence Therapeutics (Germany)

Charité - Universitätsmedizin Berlin

Oliver Keil is an author at University of Wuppertal specializing in pharmacy, gene delivery, and medicine.

ORCID

Publications per year

1995–2023

22

Publications

22

A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium

Ansgar Santel, Manuela Aleku, Oliver Keil et al. · Gene Therapy · 2006 · 365 citations

, , +16

Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression

Manuela Aleku, Petra Schulz, Oliver Keil et al. · Cancer Research · 2008 · 295 citations · Full text

, , +17

First-in-Human Phase I Study of the Liposomal RNA Interference Therapeutic Atu027 in Patients With Advanced Solid Tumors

Beate Schultheis, Dirk Strumberg, Ansgar Santel et al. · Journal of Clinical Oncology · 2014 · 257 citations

, , +17

RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy

Ansgar Santel, Manuela Aleku, Oliver Keil et al. · Gene Therapy · 2006 · 184 citations

, , +17

Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors

Dirk Strumberg, Beate Schultheis, U. Traugott et al. · International Journal of Clinical Pharmacology and Therapeutics · 2011 · 136 citations

, , +17

1–5 of 22